Correction: Hsa-mir-3163 and CCNB1 may be potential biomarkers and therapeutic targets for androgen receptor positive triple-negative breast cancer. . PLoS One 2026;21:e0352946.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

. Correction: Hsa-mir-3163 and CCNB1 may be potential biomarkers and therapeutic targets for androgen receptor positive triple-negative breast cancer. PLoS One 2026;21:e0352946.
PMID: 42406705